
STF-118804
CAS No. 894187-61-2
STF-118804( STF118804 | STF 118804 )
Catalog No. M17646 CAS No. 894187-61-2
STF-118804 is a highly specific NAMPT inhibitor; reduces the viability of most B-ALL cell lines with IC50 <10 nM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 42 | In Stock |
![]() ![]() |
5MG | 65 | In Stock |
![]() ![]() |
10MG | 88 | In Stock |
![]() ![]() |
25MG | 162 | In Stock |
![]() ![]() |
50MG | 316 | In Stock |
![]() ![]() |
100MG | 533 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameSTF-118804
-
NoteResearch use only, not for human use.
-
Brief DescriptionSTF-118804 is a highly specific NAMPT inhibitor; reduces the viability of most B-ALL cell lines with IC50 <10 nM.
-
DescriptionSTF-118804 is a potent and highly specific NAMPT inhibitor ( nicotinamide phosphoribosyl transferase inhibitor), which improves survival in an orthotopic xenotransplant model of high-risk acute lymphoblastic leukemia, and targets leukemia stem cells.
-
In Vitro——
-
In Vivo——
-
SynonymsSTF118804 | STF 118804
-
PathwayOthers
-
TargetOther Targets
-
RecptorNAMPT
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number894187-61-2
-
Formula Weight461.53
-
Molecular FormulaC25H23N3O4S
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 31 mg/mL; 67.17 mM
-
SMILESCc1ccc(cc1)S(=O)(=O)Cc1c(oc(n1)c1ccc(cc1)C(=O)NCc1cnccc1)C
-
Chemical Name4-(5-methyl-4-(tosylmethyl)oxazol-2-yl)-N-(pyridin-3-ylmethyl)benzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Matheny CJ, et al. Chem Biol. 2013, 20(11), 1352-1363.
molnova catalog



related products
-
PLpro/RBD-IN-1
PLpro/RBD-IN-1 is a dual inhibitor of SARS-CoV-2 PLpro and the spiny protein RBD, with anti-novel coronavirus activity, and is seen for the study of viral infections.
-
Atractylenolide I
Atractylenolide-I has an anti-inflammatory effect by inhibiting TNF-α and IL-6 production; ameliorates sepsis syndrome, liver and kidney functions by reduction of pro-inflammatory cytokines and LPS.
-
Abafungin
Abafungin is an antifungal agent with a broad-spectrum.